Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona A, Caraceni G, Testori A, Di Maria Grimaldi S, Dani C, Boni L, Bruzzi P, Fernandes B, Scorsetti M, Zambelli A, Gentile D; SINODAR-ONE Collaborative Group. Tinterri C, et al. Among authors: sagona a. Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215. Br J Surg. 2023. PMID: 37471574 Free PMC article. Clinical Trial.
When sentinel lymph node is intramammary.
Intra M, Garcia-Etienne CA, Renne G, Trifirò G, Rotmensz N, Gentilini OD, Galimberti V, Sagona A, Mattar D, Sangalli C, Gatti G, Luini A, Veronesi U. Intra M, et al. Among authors: sagona a. Ann Surg Oncol. 2008 May;15(5):1304-8. doi: 10.1245/s10434-007-9720-1. Epub 2007 Dec 6. Ann Surg Oncol. 2008. PMID: 18066627
Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of Oncology.
Galimberti V, Leonardi MC, Rotmensz N, Botteri E, Iodice S, Sagona A, Sahium RC, Bassani G, Berrettini A, Monti S, Gentilini O, Sangalli C, Luini A, Orecchia R, Veronesi U. Galimberti V, et al. Among authors: sagona a. Tumori. 2008 Jan-Feb;94(1):52-8. doi: 10.1177/030089160809400110. Tumori. 2008. PMID: 18468335
Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
Garcia-Etienne CA, Barile M, Gentilini OD, Botteri E, Rotmensz N, Sagona A, Farante G, Galimberti V, Luini A, Veronesi P, Bonanni B. Garcia-Etienne CA, et al. Among authors: sagona a. Ann Surg Oncol. 2009 Dec;16(12):3380-7. doi: 10.1245/s10434-009-0638-7. Ann Surg Oncol. 2009. PMID: 19649554 Clinical Trial.
Breast reconstruction: a quality measure for breast cancer care?
Garcia-Etienne CA, Forcellini D, Sagona A, Caviggioli F, Barbieri E, Cornegliani G, Giannasi S, Tinterri C. Garcia-Etienne CA, et al. Among authors: sagona a. Breast. 2012 Feb;21(1):105-6. doi: 10.1016/j.breast.2011.08.133. Epub 2011 Sep 3. Breast. 2012. PMID: 21890360 Free article.
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M, Alongi F, Fogliata A, Pentimalli S, Navarria P, Lobefalo F, Garcia-Etienne C, Clivio A, Cozzi L, Mancosu P, Nicolini G, Vanetti E, Eboli M, Rossetti C, Rubino A, Sagona A, Arcangeli S, Gatzemeier W, Masci G, Torrisi R, Testori A, Alloisio M, Santoro A, Tinterri C. Scorsetti M, et al. Among authors: sagona a. Radiat Oncol. 2012 Aug 28;7:145. doi: 10.1186/1748-717X-7-145. Radiat Oncol. 2012. PMID: 22929062 Free PMC article.
Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: a single institution experience.
Torrisi R, Garcia-Etienne CA, Losurdo A, Morenghi E, Di Tommaso L, Gatzemeier W, Sagona A, Fernandes B, Rossetti C, Eboli M, Rubino A, Barbieri E, Andreoli C, Orefice S, Gandini C, Rota S, Zuradelli M, Masci G, Santoro A, Tinterri C. Torrisi R, et al. Among authors: sagona a. Breast. 2013 Aug;22(4):419-24. doi: 10.1016/j.breast.2013.03.013. Epub 2013 May 3. Breast. 2013. PMID: 23643803
[18F]FDG PET/CT features for the molecular characterization of primary breast tumors.
Antunovic L, Gallivanone F, Sollini M, Sagona A, Invento A, Manfrinato G, Kirienko M, Tinterri C, Chiti A, Castiglioni I. Antunovic L, et al. Among authors: sagona a. Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1945-1954. doi: 10.1007/s00259-017-3770-9. Epub 2017 Jul 15. Eur J Nucl Med Mol Imaging. 2017. PMID: 28711994
Hypofractionated volumetric modulated arc therapy in ductal carcinoma in situ: toxicity and cosmetic outcome from a prospective series.
De Rose F, Fogliata A, Franceschini D, Iftode C, Torrisi R, Masci G, Sagona A, Tinterri C, Testori A, Gatzemeier W, Fernandes B, Rahal D, Cozzi L, Santoro A, Scorsetti M. De Rose F, et al. Among authors: sagona a. Br J Radiol. 2018 May;91(1085):20170634. doi: 10.1259/bjr.20170634. Epub 2018 Mar 20. Br J Radiol. 2018. PMID: 29322827 Free PMC article. Clinical Trial.
72 results